Quick Answer
Cartesian Therapeutics, Inc. reported Total Assets of $296.41 million for fiscal year 2025.
Cartesian Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $296.41M | -31.9% |
| 2024 | $435.02M | +42.6% |
| 2023 | $305.05M | +83.9% |
| 2022 | $165.89M | +3.8% |
| 2021 | $159.88M | -3.4% |
| 2020 | $165.44M | +66.2% |
| 2019 | $99.57M | +123.8% |
| 2018 | $44.48M | -56.0% |
| 2017 | $101.10M | +13.2% |
| 2016 | $89.30M | +108.5% |
| 2015 | $42.82M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $372.68M | -18.2% | -4.2% |
| June 30, 2025 | $388.89M | +11.8% | -4.9% |
| March 31, 2025 | $409.13M | +25.8% | -6.0% |
| December 31, 2024 | $435.02M | +42.6% | -4.5% |
| September 30, 2024 | $455.32M | +329.4% | +30.9% |
| June 30, 2024 | $347.74M | +149.3% | +6.9% |
| March 31, 2024 | $325.21M | +108.9% | +6.6% |
| December 31, 2023 | $305.05M | +83.9% | +187.7% |
- Cartesian Therapeutics, Inc. showed a decrease of -31.9% in Total Assets compared to the prior fiscal year.
- Over the 2015–2025 period, Cartesian Therapeutics, Inc.’s total assets has grown by 592.2% (from $42.82 million to $296.41 million).
- The most recent figure is from Cartesian Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: